Medicare Enrolled
Dr. Sreekanth Reddy, MD
Hematology & Oncology · Vidalia, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reddy
Dr. Sreekanth Reddy is a hematology & oncology specialist in Vidalia, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 81,821 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Reddy received a total of $100,988 from 84 pharmaceutical and/or device companies across 691 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 10% volume in GA
$100,988 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗81,821
Medicare services
Top 10% in GA for hematology & oncology
Not available
Unique patients (not deduplicated)
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 20,400 | $43 | $157 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
18,720 | $0 | $18 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
15,900 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 6,180 | $19 | $64 |
| Anti-nausea injection (aprepitant) | 3,640 | $1 | $6 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,719 | $0 | $1 |
| Iron infusion (Monoferric) | 2,100 | $17 | $74 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,790 | $1 | $41 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,512 | $8 | $29 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,199 | $96 | $390 |
| Injection, leucovorin calcium, per 50 mg | 996 | $3 | $14 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
900 | $2 | $7 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
678 | $87 | $654 |
| Anti-nausea injection (ondansetron/Zofran) | 624 | $0 | $3 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
554 | $22 | $103 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
463 | $97 | $421 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
420 | $18 | $120 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
290 | $63 | $277 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
273 | $2 | $39 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
267 | $11 | $67 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
260 | $8 | $9 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
244 | $74 | $210 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
179 | $16 | $65 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
173 | $122 | $509 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
165 | $22 | $164 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
161 | $49 | $205 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
138 | $48 | $208 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
98 | $1 | $4 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
96 | $42 | $177 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
79 | $10 | $40 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
74 | $2 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
70 | $11 | $66 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
65 | $25 | $105 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
60 | $15 | $63 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
54 | $16 | $83 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
53 | $23 | $135 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
52 | $4 | $12 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
47 | $1 | $22 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
39 | $3 | $11 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
22 | $76 | $324 |
| New patient office visit, complex (60-74 min) | 20 | $161 | $673 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
19 | $58 | $208 |
| Flow cytometry, 16 or more markers A laboratory test that uses lasers to analyze cells or DNA using 16 or more different markers. This technique helps identify and characterize specific cell types based on their physical and chemical properties. |
15 | $65 | $254 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
13 | $130 | $543 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.6% high complexity
90.0% medium
5.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$100,988
Total received (2018-2024)
Avg $14,427/year across 7 years
Top 5% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
691
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$18,430
2023
$30,444
2022
$5,429
2021
$6,718
2020
$5,065
2019
$33,307
2018
$1,596
Payments by company (2024)
Astellas Pharma US Inc
$12,265
GENZYME CORPORATION
$1,719
PFIZER INC.
$1,504
Celgene Corporation
$403
Merck Sharp & Dohme LLC
$240
Bayer Healthcare Pharmaceuticals Inc.
$219
Novartis Pharmaceuticals Corporation
$159
Janssen Biotech, Inc.
$151
E.R. Squibb & Sons, L.L.C.
$148
Tempus AI, Inc
$135
Eisai Inc.
$128
GlaxoSmithKline, LLC.
$104
AstraZeneca Pharmaceuticals LP
$95
Genentech USA, Inc.
$89
Takeda Pharmaceuticals U.S.A., Inc.
$83
SOBI, INC
$81
Daiichi Sankyo Inc.
$79
Gilead Sciences, Inc.
$66
Karyopharm Therapeutics Inc.
$66
ADC Therapeutics America, Inc.
$54
Regeneron Healthcare Solutions, Inc.
$52
ABBVIE INC.
$51
Lilly USA, LLC
$50
Stemline Therapeutics Inc.
$49
Incyte Corporation
$43
Exelixis Inc.
$41
TAIHO ONCOLOGY, INC.
$40
SERVIER PHARMACEUTICALS LLC
$32
TerSera Therapeutics LLC
$31
Adaptive Biotechnologies Corporation
$24
Fennec Pharmaceuticals, Inc.
$23
ARRAY BIOPHARMA INC
$23
Mirati Therapeutics, Inc.
$21
Agios Pharmaceuticals, Inc.
$21
Ipsen Biopharmaceuticals, Inc
$20
Deciphera Pharmaceuticals Inc.
$20
JAZZ PHARMACEUTICALS INC.
$19
PUMA BIOTECHNOLOGY, INC.
$19
Alexion Pharmaceuticals, Inc.
$19
BeiGene USA, Inc.
$17
SHIELD THERAPEUTICS INC
$15
Myriad Genetic Laboratories, Inc.
$14
Top 3 companies account for 84.0% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic USA, Inc.
$19,948
Seagen Inc.
$15,486
Astellas Pharma US Inc
$12,484
Celgene Corporation
$10,413
GENZYME CORPORATION
$9,206
Coherus Biosciences Inc.
$7,060
Novartis Pharmaceuticals Corporation
$5,508
ABBVIE INC.
$2,467
AstraZeneca Pharmaceuticals LP
$2,217
Genentech USA, Inc.
$1,997
PFIZER INC.
$1,826
E.R. Squibb & Sons, L.L.C.
$1,732
CTI BioPharma Corp.
$1,466
Rigel Pharmaceuticals, Inc.
$1,193
Merck Sharp & Dohme LLC
$711
Exelixis Inc.
$500
Bayer Healthcare Pharmaceuticals Inc.
$456
Medtronic, Inc.
$420
Janssen Biotech, Inc.
$405
Merck Sharp & Dohme Corporation
$350
Amgen Inc.
$288
Eisai Inc.
$280
Daiichi Sankyo Inc.
$276
Stemline Therapeutics Inc.
$234
GlaxoSmithKline, LLC.
$214
Gilead Sciences, Inc.
$197
Takeda Pharmaceuticals U.S.A., Inc.
$196
Puma Biotechnology, Inc.
$175
Incyte Corporation
$175
Seattle Genetics, Inc.
$157
Lilly USA, LLC
$148
Janssen Pharmaceuticals, Inc
$146
Tempus AI, Inc
$135
Mirati Therapeutics, Inc.
$121
JAZZ PHARMACEUTICALS INC.
$120
Pharmacyclics LLC, An AbbVie Company
$119
Karyopharm Therapeutics Inc.
$118
Ipsen Biopharmaceuticals, Inc
$116
THD AMERICA, INC.
$113
Regeneron Healthcare Solutions, Inc.
$111
Deciphera Pharmaceuticals Inc.
$106
Janssen Scientific Affairs, LLC
$95
TerSera Therapeutics LLC
$86
Foundation Medicine, Inc.
$82
SOBI, INC
$81
G1 Therapeutics, Inc.
$74
Alexion Pharmaceuticals, Inc.
$67
BeiGene USA, Inc.
$63
EISAI INC.
$61
Pharmacyclics LLC, an AbbVie Company
$59
Bayer HealthCare Pharmaceuticals Inc.
$58
ADC Therapeutics America, Inc.
$54
EAGLE PHARMACEUTICALS, INC.
$54
Dendreon Pharmaceuticals LLC
$52
Clovis Oncology, Inc.
$52
Agios Pharmaceuticals, Inc.
$40
EUSA Pharma (US) LLC
$40
TAIHO ONCOLOGY, INC.
$40
Verastem, Inc.
$36
Epizyme, Inc.,
$36
SERVIER PHARMACEUTICALS LLC
$32
EMD Serono, Inc.
$31
Taiho Oncology, Inc.
$29
AVEO Pharmaceuticals, Inc.
$26
Adaptive Biotechnologies Corporation
$24
Fennec Pharmaceuticals, Inc.
$23
ARRAY BIOPHARMA INC
$23
AbbVie, Inc.
$21
MorphoSys, US Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$19
PUMA BIOTECHNOLOGY, INC.
$19
Global Blood Therapeutics, Inc.
$17
Servier Pharmaceuticals LLC
$17
Dova Pharmaceuticals
$17
Heron Therapeutics, Inc.
$17
Teleflex LLC
$16
PharmaEssentia USA Corporation
$16
AMAG Pharmaceuticals, Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Blue Earth Diagnostics Limited
$15
SHIELD THERAPEUTICS INC
$15
Octapharma USA, Inc.
$14
Myriad Genetic Laboratories, Inc.
$14
Pharmacosmos Therapeutics Inc.
$13
Top 3 companies account for 47.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · AFINITOR · ARROW · Alecensa · Avastin · Axumin · BAVENCIO · BESREMI · BOSULIF · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · Creon · Cresemba · DARZALEX · DOPTELET · Doptelet · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · Enhertu · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE LIQUID CDX · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Gazyva · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · Itovebi · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMFEXY · PIQRAY · PLUVICTO · POLIVY · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · Quzyttir · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SYLVANT · Stivarga · Sylvant · TAGRISSO · TALVEY · TAZVERIK · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
1
County median income
$54,130
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HEALTH MEADOWS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 10% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Reddy performed 20,400 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $100,988 from 84 companies across 691 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other hematology & oncology specialists in Vidalia?
Dr. Reddy's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Vidalia
Browse hematology & oncology specialists in Vidalia ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology